Betmiga 50mg Tablet
Product Info
| Prescription required | Yes |
| Marketer | Astellas Pharma Inc |
| Active Ingredient | Mirabegron (50mg) |
| Storage | Store below 30°C |
| Chemical Class | Anilide Derivative |
| Habit Forming | No |
| Therapeutic Class | UROLOGY |
| Action Class | Selective beta 3-adrenoceptor agonist (Bladder) |
| User Rating | 4.8 |
| User Reviews | 475 |
FAQ
Do I need to be careful while taking Betmiga 50mg if I am taking medicines to control my blood pressure?
Yes, you need to be careful while taking Betmiga 50mg if you have high blood pressure. Keep a regular check on your blood pressure since Betmiga 50mg can cause an increase in blood pressure in some people. It should not be used in patients with severe uncontrolled hypertension.
Can I take Betmiga 50mg off and on?
No, you need to take it daily as directed by your doctor since it controls your condition and does not cure it. Your bladder takes time to adapt to the medicine, so if you take it off and on, you will not get the desired benefits and your symptoms will recur.
What if I accidentally take more than the required dose of Betmiga 50mg?
You should seek urgent medical attention even if do not feel any discomfort. Overdose of Betmiga 50mg may increase your pulse rate and blood pressure. As a result of this, you may experience severe headache, palpitations, chest pain and fatigue.
How long does it take for Betmiga 50mg to show its effects?
You may see the full benefits of Betmiga 50mg after 8 weeks of starting the treatment or longer. Depending on how well the medicine suits and affects the patient, the dose can be increased after 4-8 weeks.
Does Betmiga 50mg affect the kidneys?
Infection of kidneys, ureters, urinary bladder or urethra is a common side effect of Betmiga 50mg but does not affect everyone. Very few patients have reported of developing renal stones and bladder pain with the use of Betmiga 50mg. Also, patients with compromised kidney function should be careful while using Betmiga 50mg and report any unwanted symptoms related to kidneys to the consulting doctor.
Does Betmiga 50mg cause loss of sleep?
No, Betmiga 50mg does not affect your sleep. However, if you are having any problems related to your sleep, talk to your doctor.
Can I stop taking Betmiga 50mg if I start feeling better?
No, do not stop taking Betmiga 50mg even if you start feeling better. This medicine does not cure overactive bladder but relieves the symptoms of urgency, frequency and incontinence (unable to control when you empty your bladder). Stopping treatment may result in a recurrence of the symptoms of overactive bladder.
What is the effect of Betmiga 50mg in children?
It is best to avoid the use of Betmiga 50mg in children because its effectiveness and side effects in children (age < 18 years) have not been studied yet.
What if you forget to take Betmiga Tablet?
If you miss a dose of Betmiga 50mg, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Betmiga 50mg Tablet Reviews
Betmiga 50mg is used to treat symptoms of overactive bladder that includes increased or frequent urination, urgent need to urinate and inability to control urination. It helps to relax the muscle surrounding the bladder and increase it's ability to store urine.
Betmiga 50mg is advised to take it in a dose and duration as per prescription. It can be taken with or without food. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.
Some common side effects of this medicine are constipation, headache, high blood pressure, nasal inflammation, urinary tract infection, rapid heartbeat, and joint pain. If any of the side effects bother you or persist, consult the doctor without delay.
Before receiving the treatment, inform your doctor if you are on any medication for any other health condition. If you are pregnant or breastfeeding, tell your doctor prior to the treatment. Patients with liver or kidney disease must be cautious while receiving the prescription and they must receive regular follow-ups as per the doctor’s advice.
Betmiga 50mg is advised to take it in a dose and duration as per prescription. It can be taken with or without food. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.
Some common side effects of this medicine are constipation, headache, high blood pressure, nasal inflammation, urinary tract infection, rapid heartbeat, and joint pain. If any of the side effects bother you or persist, consult the doctor without delay.
Before receiving the treatment, inform your doctor if you are on any medication for any other health condition. If you are pregnant or breastfeeding, tell your doctor prior to the treatment. Patients with liver or kidney disease must be cautious while receiving the prescription and they must receive regular follow-ups as per the doctor’s advice.
How Betmiga 50mg Tablet Works
Betmiga 50mg is a beta 3-receptor agonist. It works by activating the receptor in the bladder, causing the bladder muscles to relax. It prevents frequent, urgent or uncontrolled urination.
How to Use Betmiga 50mg Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Betmiga 50mg may be taken with or without food, but it is better to take it at a fixed time.
Benefits of Betmiga 50mg Tablet
- In Treatment of Overactive bladder (OAB) symptoms: Betmiga 50mg helps to treat uncontrollable contractions (spasms) of the bladder muscles that cause frequent urination, urgent need to urinate, and inability to control the passing of urine. It also relieves painful, or frequent urination and reduces the urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.
Uses of Betmiga 50mg Tablet
- Treatment of Overactive bladder (OAB) symptoms
Betmiga 50mg Tablet Side Effects
Safety Tips
Liver
CAUTION
Betmiga 50mg should be used with caution in patients with liver disease. Dose adjustment of Betmiga 50mg may be needed. Please consult your doctor.Use of Betmiga 50mg is not recommended in patients with severe liver disease.
Breast feeding
CONSULT YOUR DOCTOR
Betmiga 50mg is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
SAFE
Betmiga 50mg does not usually affect your ability to drive.
Pregnancy
CONSULT YOUR DOCTOR
Betmiga 50mg may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Kidney
CAUTION
Betmiga 50mg should be used with caution in patients with severe kidney disease. Dose adjustment of Betmiga 50mg may be needed. Please consult your doctor.
Alcohol
CAUTION
Caution is advised when consuming alcohol with Betmiga 50mg. Please consult your doctor.
Quick Tips
- Do not stop taking this medicine if you do not notice an improvement in your symptoms as it may take some time for your bladder to adapt and your symptoms to improve.
- It causes less drowsiness and constipation than other medicines for overactive bladder.
- It may raise your blood pressure. Monitor your blood pressure regularly.
- Betmiga 50mg helps you to have better control over your urination. It relaxes your bladder which increases its capacity to hold urine thereby reducing the need to pass urine.
References
- Mirabegron. Norman, Oklahoma: Astellas Pharma Technologies, Inc; 2012.
- Mirabegron. Chertsey, Surrey: Astellas Pharma Ltd.; 2012 [revised 18 Sep. 2017].
- Medscape. Mirabegron.
- National Health Services. Mirabegron. [Last Reviewed: 28 Jul. 2020].
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 924-25.
- CiplaMed. Mirabegron [Prescribing Information]. [Last Reviewed: Jan. 2019].